台股 » 個股 » 國光生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

國光生

(4142)
可現股當沖
  • 股價
    27.90
  • 漲跌
    ▼0.30
  • 漲幅
    -1.06%
  • 成交量
    701
  • 產業
    上市 生技醫療類股▼0.62%
  • 633人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
國光生 (4142)籌碼相關-凱基-澄新 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-澄新 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2019/11/0100.00125.0025.65-11,927-0.05%
2019/10/31825.5600.0025.1081,9060.42%
2019/10/2100.00125.9025.80-11,927-0.05%
2019/09/0500.00226.1026.10-22,655-0.08%
2019/09/03226.05825.7325.80-62,621-0.23%
2019/09/02225.80625.9225.70-42,603-0.15%
2019/08/3000.00825.0025.10-82,479-0.32%
2019/08/2900.00125.0025.10-12,448-0.04%
2019/08/28124.6500.0025.1012,4110.04%
2019/08/27124.00123.5524.2002,3220.00%
2019/08/15222.3000.0022.4522,4310.08%
2019/08/14122.7000.0022.8012,4300.04%
2019/08/13122.7500.0022.6512,4470.04%
2019/08/12122.9000.0022.7012,5100.04%
2019/08/07623.0400.0022.9562,4770.24%
2019/08/06922.3300.0022.8092,4730.36%
2019/07/2500.00123.4523.10-12,377-0.04%
2019/07/1900.00124.2024.15-12,282-0.04%
2019/07/1800.00224.2324.25-22,262-0.09%
2019/07/1600.00123.4524.00-12,207-0.05%
2019/07/1200.00123.8023.70-12,186-0.05%
2019/07/09324.4700.0024.6032,0720.14%
2019/07/08323.78423.0823.70-11,988-0.05%
2019/07/0500.00222.8523.10-22,024-0.10%
2019/07/0400.00422.8323.10-42,074-0.19%
2019/07/02222.4800.0022.2521,9590.10%
2019/07/01521.95121.8022.1041,9040.21%
2019/06/28321.4500.0021.5531,8360.16%
2019/06/2000.001120.0520.10-111,761-0.62%
2019/06/1900.00220.1520.10-21,750-0.11%
2019/06/18219.9000.0020.0521,7350.12%
2019/05/310.619.5500.0019.500.61,6140.04%
2019/05/3000.00119.3519.50-11,608-0.06%
2019/05/2700.00319.2519.25-31,577-0.19%
2019/05/2300.00219.3319.55-21,535-0.13%
2019/05/2100.00120.3020.25-11,419-0.07%
2019/05/2000.00220.4020.20-21,413-0.14%
2019/05/171220.2800.0020.40121,3980.86%
2019/05/080.219.7000.0019.650.21,3540.01%
2019/04/2300.00420.4020.40-41,217-0.33%
2019/03/2100.00220.0519.95-2673-0.30%
2019/03/14021.7500.0019.9506890.00%
2019/03/11021.50120.2020.20-1739-0.14%
2019/03/06021.9000.0020.0009190.00%
2019/02/21119.9500.0019.9519680.10%
2019/02/1400.00120.2520.30-11,016-0.10%
2019/02/13119.9000.0019.9011,0500.10%
2019/02/1200.00119.9019.95-11,134-0.09%
2019/02/11119.9500.0019.9011,1420.09%
2019/01/2400.00120.3020.25-11,241-0.08%
2019/01/08420.8000.0020.6042,0240.20%
2018/12/18221.6300.0021.4523,7150.05%
2018/12/1700.00122.1522.20-13,710-0.03%
2018/12/1300.00121.6021.55-13,717-0.03%
2018/12/10221.30221.5321.3503,8260.00%
2018/12/06222.13122.4021.8013,9760.03%
2018/12/03222.8300.0022.8023,9170.05%
2018/11/3000.00223.3523.10-23,877-0.05%
2018/11/29120.6000.0022.0013,7710.03%
2018/11/2800.001021.0021.00-103,720-0.27%
2018/11/12121.5500.0021.6013,5300.03%
2018/11/0900.00122.3522.35-13,482-0.03%
2018/10/3100.00120.5020.30-13,308-0.03%
2018/10/30120.30219.7020.30-13,291-0.03%
2018/10/29221.7800.0021.6023,2300.06%
2018/10/26121.7500.0022.4013,1910.03%
2018/10/24124.0000.0023.0013,0870.03%
2018/10/2300.00224.1524.05-23,036-0.07%
2018/10/2200.00324.6824.55-33,010-0.10%
2018/10/19525.0800.0024.7053,0170.17%
2018/10/1800.00225.9525.75-23,013-0.07%
2018/10/1700.00124.2524.95-12,981-0.03%
2018/10/16124.1000.0024.0512,9900.03%
2018/10/15124.9500.0024.5512,9100.03%
2018/10/1200.00825.5325.30-82,825-0.28%
2018/10/11523.55123.5525.0042,6520.15%
2018/10/091525.8700.0026.15152,4680.61%
2018/10/0800.001424.9726.30-142,274-0.62%
2018/10/05722.99424.0024.3532,0970.14%
2018/10/04523.8500.0024.0051,9780.25%
2018/10/03224.85125.4024.9011,8940.05%
2018/10/0200.00722.7724.50-71,635-0.43%
2018/10/01322.07122.9522.9521,3820.14%
2018/09/28520.4500.0020.9051,1730.43%
2018/09/2500.001119.6019.60-111,149-0.96%
2018/09/21320.3000.0020.0031,1400.26%
2018/09/2000.00120.1020.20-11,129-0.09%
2018/09/18520.55420.7020.6011,0890.09%
2018/09/17119.00119.0019.0501,0140.00%
2018/09/13820.9700.0020.5089610.83%
2018/08/2100.00218.1518.50-2819-0.24%
2018/08/0600.00120.2520.25-1800-0.12%
2018/07/26119.55419.8319.55-3702-0.43%
2018/07/24420.2000.0020.0045870.68%
2018/04/09220.30220.6021.0008990.00%
2018/04/0300.00120.2019.75-1829-0.12%
2018/01/1600.00321.1721.10-3905-0.33%
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
國光生 相關文章